We recognize that we can’t address major health, environmental and economic challenges alone, so we collaborate with others who share our commitment and who bring their own unique expertise to the table.
We conduct stakeholder engagement at both the corporate and the local level, depending on the issue. We engage with industry, governments, policy makers, nongovernmental organizations (NGOs), opinion leaders, patient groups, academic organizations, our employees and others to inform our policies, our practices and the development of our products. Our intention is to build lasting relationships with our stakeholders; to understand their objectives, their expectations of our company and the potential for collaboration; and to enhance mutual trust and understanding.
We strive to exchange information, views and recommendations; to share activities and progress toward key goals; and to work in partnership toward common objectives. Engagement may take the form of one-on-one meetings, expert-input forums, roundtable discussions, industry coalitions or formal partnerships.
We engage with a diverse group of stakeholders to more fully understand their needs and expectations, and to gain insights that can inform our efforts to improve access to health care and foster progress toward solutions that benefit society and support our business.
Patients and caregivers
We embrace the opportunity to engage with individual patients, patient advocacy organizations and caregivers to better understand their health care journeys, expected outcomes and decision-making considerations. Learn more about our work with patient groups.
Health care professionals
We are committed to providing appropriate and balanced information to physicians and other health care providers about our medicines, vaccines and ongoing research. Learn more about our interactions with health care professionals.
We work with payers worldwide to inform their understanding of the relationship between the prices of our products and the true value they deliver to patients and health care systems. Learn more about our pricing practices.
Governments, multilateral organizations and regulators
We work with policy makers, legislators, multilateral organizations and governments worldwide to ensure that policy and regulatory environments globally, nationally and locally foster patient access to medicines and vaccines, and that they are conducive to ethical business practices, science and innovation. Learn more about our public policy and advocacy positions.
We strive to create shareholder value by identifying opportunities to meet customer needs and by managing our business responsibly to achieve superior financial results over the long term. Learn more about how we engage with shareholders.
International and local organizations
We work hard to identify the best organizations and individuals to collaborate with in order to address societal challenges and to inform debate on pressing issues. Learn more about how we collaborate with others.
We work toward developing culturally appropriate mechanisms to engage and build relationships with our local community stakeholders.
We work to reduce the environmental effects of our operations and products and to promote sustainable environmental practices within the company, among our partners and throughout our supply chain.
We strive to foster a positive and inclusive working environment for our employees by providing resources to improve their health and that of their families, opportunities to further their professional development and ways to get more involved in the communities where they live. Learn more about our employee relations efforts.
Suppliers and business partners
We strive to engage a diverse supplier base and to encourage responsible approaches on the part of suppliers regarding labor, employment, human rights, health and safety, ethics, diversity and protection of the environment. Learn more about our approach to procurement and supplier relations.
Trade and industry associations
We engage with stakeholders through membership in numerous organizations. Within these groups, we aim to inform relevant debates in ways that are constructive and that ultimately foster improved patient access to medicines and vaccines globally.
We welcome your comments, questions and feedback to help guide the development of our programs, our reporting efforts and our corporate responsibility website. Contact us.